Radhakrishnan P. Iyer
No más puestos en curso
Origen de la red de primer grado Radhakrishnan P. Iyer.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 25 | |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.
4
| Extinct | Biotechnology | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Radhakrishnan P. Iyer a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer Corporate Officer/Principal | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal | |
| University Of Dundee | College/University | Undergraduate Degree Doctorate Degree | |
| Henley Management College | College/University | Masters Business Admin | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | Chairman | |
| PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Aescap Venture Management BV
 Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Investment Managers | Private Equity Investor | |
i-Optics BV
 i-Optics BV Medical SpecialtiesHealth Technology i-Optics BV develops and produces eye diagnosis and therapeutic solutions. Its lead product, the EasyScan, that provides non-mydriatic retina imaging camera for the diagnosis of diabetic retinopathy and macular degeneration. The firm engages in the development and marketing of retina and cornea imaging solutions. The company was founded by Michiel Mensink and is headquartered in The Hague, the Netherlands. | Medical Specialties | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| Office for Strategic Co-ordination of Health Research | Director/Board Member | ||
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Chief Executive Officer | |
| MedCity Ltd. | Chairman | ||
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | President Chairman | |
F-Star Beta Ltd.
 F-Star Beta Ltd. BiotechnologyHealth Technology F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Creabilis SA | Chief Executive Officer | ||
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
F-Star Delta Ltd.
 F-Star Delta Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., F-Star Delta Ltd. develops antibody products to improve the treatment of serious diseases. The company is based in Cambridge, UK and was founded in 2016. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| GALECTO, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
Ochre Bio Ltd.
 Ochre Bio Ltd. Pharmaceuticals: MajorHealth Technology Ochre Bio Ltd. is a biotechnology company based in Headington, UK. Ochre Bio is focused on developing RNA medicines for chronic liver diseases. The British company uses deep phenotyping, precision RNA medicine, and testing in live human donor livers to develop therapies for important liver health challenges. The company's goal is to develop therapies that increase donor liver supply and reduce cirrhosis complications. The company was founded by Quin Wills and the CEO is Jack O'Meara. | Pharmaceuticals: Major | Chairman | |
| IMMATICS N.V. | Biotechnology | Director/Board Member | |
| F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Executive Officer | |
| Spinifex Pty Ltd. | Director/Board Member | ||
| Atlantic Pharmaceuticals (Holdings) Ltd. | Director/Board Member | ||
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Pharmaceuticals: Major | Chief Executive Officer | |
| Liverpool Health Partners Ltd. | Chairman | ||
Tessellate Bio BV
 Tessellate Bio BV BiotechnologyHealth Technology Tessellate Bio BV is a Dutch preclinical stage biotechnology company that focuses on discovering and developing precision oncology medicines. The company is based in Naarden, the Netherlands. The company's mission is to turn cancer patients into cancer survivors by targeting unexplored or difficult to drug pathways beyond HRD. The company is also developing companion diagnostics, including a potentially diagnostic to detect ALT positive cancers. Led by an experienced team of drug hunters, Tessellate Bio is building a pipeline of first-in-class medicines based on cutting-edge research. The company was founded by Hilda A. Pickett and the CEO is Andree Blaukat. | Biotechnology | Director/Board Member | |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
Pfizer Holdings International Luxembourg (PHIL) SARL
 Pfizer Holdings International Luxembourg (PHIL) SARL Financial ConglomeratesFinance Part of Pfizer Inc., Pfizer Holdings International Luxembourg (PHIL) SARL is an investment holding company. The company is based in Luxembourg, Luxembourg. | Financial Conglomerates | Corporate Officer/Principal |
Estadísticas
Internacional
| Reino Unido | 27 |
| Estados Unidos | 13 |
| Países Bajos | 5 |
| Australia | 3 |
| Luxemburgo | 3 |
Sectorial
| Health Technology | 36 |
| Consumer Services | 5 |
| Finance | 4 |
| Commercial Services | 3 |
Operativa
| Director/Board Member | 158 |
| Corporate Officer/Principal | 80 |
| Chief Executive Officer | 41 |
| Independent Dir/Board Member | 41 |
| Director of Finance/CFO | 27 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Nessan Bermingham | 36 |
| Eliot Forster | 35 |
| Edward Benz | 29 |
| Darlene Deptula-Hicks | 24 |
| Patrick Johan Hendrik Krol | 22 |
| Scott Smith | 21 |
| Todd Brady | 20 |
| David Arkowitz | 20 |
| Pamela Klein | 19 |
| Geoff Race | 17 |
| Martin Driscoll | 16 |
| Mark Wiggins | 15 |
| Timothy Clackson | 11 |
| Kurt M. Eichler | 10 |
| Christiana Goh Bardon | 10 |
- Bolsa de valores
- Insiders
- Radhakrishnan P. Iyer
- Conexiones Empresas
